Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

There are no proven, effective therapies for polycystic kidney disease (PKD) or polycystic liver disease (PLD). We enrolled 42 patients with severe PLD resulting from autosomal dominant PKD (ADPKD) or autosomal dominant PLD (ADPLD) in a randomized, double-blind, placebo-controlled trial of octreotid...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hogan, Marie C., Masyuk, Tetyana V., Page, Linda J., Kubly, Vickie J., Bergstralh, Eric J., Li, Xujian, Kim, Bohyun, King, Bernard F., Glockner, James, Holmes, David R., Rossetti, Sandro, Harris, Peter C., LaRusso, Nicholas F., Torres, Vicente E.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2010
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900957/
https://ncbi.nlm.nih.gov/pubmed/20431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009121291
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki